Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2008
07/16/2008CN101222941A A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNF alpha and a carrier protein
07/16/2008CN101222940A Uses of RHCC peptide in drug delivery, renal filtering, chemical catalysis and production of nanoparticles
07/16/2008CN101222939A Preservative composition for ophthalmic use
07/16/2008CN101220143A Production method of polyether carbonic acid ester with heat reversible gel rubber
07/16/2008CN101220093A Biological degradable albumin derivant, pharmacy composition, preparation and application of the same
07/16/2008CN101220025A Micronized crystalline tiotropium bromide
07/16/2008CN101219220A Remifentanil polymer sustained-release analgesic and its preparing process
07/16/2008CN101219219A Complex containing vascellum chalone or its fragment, preparation method and application thereof
07/16/2008CN101219218A Temperature sensing parents block polymer/iron oxide magnetic nano-carrier, preparation method and application thereof
07/16/2008CN101219217A Adjuvant composition and methods for its use
07/16/2008CN101219209A Insulin-protamine zinc injection and method for preparing the same
07/16/2008CN101219207A Application of recombined human vascellum esoderma inhibin in medicine preparation
07/16/2008CN101219206A Application of recombined human vascellum esoderma inhibin in medicine preparation
07/16/2008CN101219201A Traditional Chinese medicine liquid capsule and its preparing method
07/16/2008CN101219187A Method for preparing Chinese medicine of condensed pill for preventing brain decline
07/16/2008CN101219182A Method for preparing thin film clothing Liuwei Dihuang dropping pills
07/16/2008CN101219167A Method for preparing capsule for expelling stone
07/16/2008CN101219159A Root of pseudo-ginseng corn plaster
07/16/2008CN101219154A Microorganism additive agent for improving phylactic power of pets and accelerating growth
07/16/2008CN101219150A Rapidly effectual aluminum magnesium carbonate preparation and technique of preparing the same
07/16/2008CN101219147A Dectancyl mastication tablet for dogs and cats
07/16/2008CN101219144A Long-circulation nano-grain of hydroxycamptothecin and method for preparing the same
07/16/2008CN101219140A Benzydamine Hcl soluble tablet and method for preparing the same
07/16/2008CN101219136A Oral capsule agent for preventing and treating AIDS and method for preparing the same
07/16/2008CN101219133A Levorotation carnitine pellet and method for preparing the same
07/16/2008CN101219132A Method for applying calcium polyenoic acid for medical and beauty treatment fields
07/16/2008CN101219128A Dexibuprofen pharmaceutical composition with improved dissolving out capability and method for preparing the same
07/16/2008CN101219127A Voglibose dispersible tablet, capsule and method for preparing the same
07/16/2008CN101219126A Beta-carotene pellet and method for preparing the same
07/16/2008CN101219124A Hydrochloric acid cefetamet pivoxil dispersible tablet and method for preparing the same
07/16/2008CN101219120A Telmisartan dispersible tablet and method for preparing the same
07/16/2008CN101219119A Method of preparing simvastatin sustained-release microsphere carried series
07/16/2008CN101219118A Impulse released oral medication preparation and method for preparing the same
07/16/2008CN101219117A Cefamandole nafate powder injection, production method of powder injection and raw machine thereof
07/16/2008CN101219115A Sustained drug-relase particles and process for producing the same
07/16/2008CN101219113A Compound anticancer sustained-release injection containing bendamustine
07/16/2008CN101219112A Compound anticancer sustained-release injection containing bendamustine
07/16/2008CN101219111A Anticancer injection containing bendamustine and its potentiating agent
07/16/2008CN101219110A Sustained-release injection containing methotrexate potentiating agent
07/16/2008CN101219108A Drug delivery of phase changing formulation
07/16/2008CN101219107A Imatinib sustained-release implantation agent for treating solid tumors
07/16/2008CN101219106A Telatinib sustained-release implantation agent for treating solid tumors
07/16/2008CN101219105A Emtricitabine sustained-release implantation agent for treating solid tumors
07/16/2008CN101219104A Cladribine sustained-release implantation agent for treating solid tumors
07/16/2008CN101219103A Tipifarnib sustained-release implantation agent for treating solid tumors
07/16/2008CN101219102A Lapatinib sustained-release implantation agent for treating solid tumors
07/16/2008CN101219101A Fludarabine sustained-release implantation agent for treating solid tumors
07/16/2008CN101219071A Tumour target thermotherapy method based on metallic grain or its compound thermal chemical reaction
07/16/2008CN100402580C Modified bio-related substance, process for producing the same, and intermediate
07/16/2008CN100402512C Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers
07/16/2008CN100402087C Lyophilized suspended powder injection and preparation method thereof
07/16/2008CN100402086C Slow released nano microsphere gel of alkaline fibroblast growth factor and polylactic acid and its preparing method
07/16/2008CN100402033C Fleroxacin injection and its preparing method
07/16/2008CN100402031C Parenteral formulations containing a rapamycin hydroxyester
07/16/2008CN100402025C Modified release pharmaceutical formulation
07/16/2008CN100402021C Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
07/16/2008CN100402017C Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
07/16/2008CN100401887C Antimicrobial envelopes
07/15/2008US7399860 Manufacture of polyglutamate-therapeutic agent conjugates
07/15/2008US7399839 soluble proteins containing free cysteine residues and having increased efficiency
07/15/2008US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers
07/15/2008US7399772 Substituted benzimidazole dosage forms and method of using same
07/15/2008US7399747 Peptides carrying substances across the blood brain barrier
07/15/2008US7399645 Formed by fusing a pinanediol bound to a solid support with a boronic or boric acid bound to a biomolecule; an array may be constructed by preparing the conjugate at a plurality of spatially distinct reaction sites on the solid support
07/15/2008US7399528 Powder particles with smooth surface for use in inhalation therapy
07/15/2008US7399492 Composition and method for issue repair and regeneration
07/15/2008US7399486 Continuously introducing the mixed fluids into a dryer from the two or more different fluids for preparation of sustained release microspheres containing a biodegradable polymer, a drug, an additive and a solvent with different types of contents or both of the components, by controlling the mixing ratios
07/15/2008US7399485 Rapidly Disintegrable solid preparation
07/15/2008US7399482 Thin film medication device and kit
07/15/2008US7399481 Methods for treating, maintaining, or improving fur or hair pigmentation of domestic carnivores using a composition comprising free tyrosine
07/15/2008US7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor
07/15/2008US7399463 HSA-free formulations of interferon-beta
07/15/2008US7399461 Prostate-specific membrane antigen and uses thereof
07/15/2008CA2441836C New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kitfor preparation of the liver cancer-treating composition
07/15/2008CA2426018C Methods and apparatus for making seamless capsules
07/15/2008CA2397942C Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation
07/15/2008CA2395530C Calcium formate for use as a phosphorus binder and a dietary supplement
07/15/2008CA2391393C Film preparation for biphasic release of pharmacologically active or other substances
07/15/2008CA2378892C Preserved pharmaceutical formulations
07/15/2008CA2371940C Pregelatinized starch in a controlled release formulation
07/15/2008CA2355175C Soluble compositions of triphenylethylene antiestrogens
07/15/2008CA2298487C A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
07/15/2008CA2283327C Cationic lipid compositions targeting angiogenic endothelial cells
07/15/2008CA2247848C Nitric oxide donors capable of reducing toxicity from drugs
07/15/2008CA2239775C Crosslinked polymer compositions and methods for their use
07/15/2008CA2231545C Oral gel capsule formulation of 1,2,4-benzotriazine oxides
07/15/2008CA2207103C Methods to identify hemochromatosis
07/15/2008CA2205557C Monofunctional and/or polyfunctional polylysine conjugates
07/15/2008CA2183684C Inoculation of animals with dried, pelleted biological materials
07/15/2008CA2160938C Muscle relaxant pharmaceutical compositions
07/15/2008CA2149329C Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
07/14/2008CA2677686A1 Color-marked oligosaccharides or polysaccharides
07/14/2008CA2677260A1 Golden mean harmonized water and aqueous solutions
07/10/2008WO2008083370A2 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid
07/10/2008WO2008082948A2 Ophthalmic alginate composition related methods of manufacture and methods of use
07/10/2008WO2008082669A2 Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage
07/10/2008WO2008082613A2 Factor ix moiety-polymer conjugates having a releasable linkage
07/10/2008WO2008081940A1 Gel composition for treating mycosis
07/10/2008WO2008081917A1 Spherical ferrite nanoparticle and method for production thereof
07/10/2008WO2008081901A1 Pharmaceutical alkyl gallate composition